Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Thursday . The company traded as low as $23.14 and last traded at $23.47, with a volume of 36618 shares changing hands. The stock had previously closed at $24.02. Analyst Ratings Changes MIRM has been the […]
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) – Equities researchers at HC Wainwright dropped their FY2023 EPS estimates for Mirum Pharmaceuticals in a research note issued on Tuesday, February 27th. HC Wainwright analyst E. Arce now forecasts that the company will earn ($2.44) per share for the year, down from their previous estimate of ($2.13). […]
Healthcare of Ontario Pension Plan Trust Fund bought a new stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 100,000 shares of the company’s stock, valued at approximately $3,160,000. Healthcare of Ontario Pension […]
Jump Financial LLC increased its position in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 607.0% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 87,384 shares of the company’s stock after purchasing an additional 75,024 shares during the quarter. Jump […]
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) – Stock analysts at HC Wainwright lifted their FY2025 earnings per share (EPS) estimates for shares of Mirum Pharmaceuticals in a research note issued on Tuesday, January 9th. HC Wainwright analyst E. Arce now expects that the company will post earnings per share of $3.37 for the year, […]